Education
About Us
Working with TipRanks
Follow Us
Regeneron (REGN)
NASDAQ:REGN
Regn7041
Active Noninfectious Uveitis Affecting The Posterior Segment
Phase I/II
Not Yet Recruiting
A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants
Oct 16, 2025
―
Aln-Snca
Parkinsons Disease
Phase I
Not Yet Recruiting
First-in-Human Study of ALN-SNCA in Adult Participants With Early Parkinson's Disease (PD)
Oct 09, 2025
―
Regn7508, Acetylsalicylic Acid (Asa)
Symptomatic Venous Thromboembolism (Vte)
Phase III
Not Yet Recruiting
REGN7508 Versus Acetylsalicylic Acid (ASA) for Venous Thromboprophylaxis After Total Knee Arthroplasty in Adult Participants
Oct 03, 2025
―
Aln-Cfb
Paroxysmal Nocturnal Hemoglobinuria (Pnh), Persistent Anemia
Phase I/II
Not Yet Recruiting
A First-in-Human Safety and Efficacy Study of ALN-CFB, a Small Interfering RNA (siRNA) Targeting Complement Factor B, in Adult Participants With Paroxysmal Nocturnal Hemoglobinuria With Persistent Anemia on a C5 Inhibitor
Sep 18, 2025
―
Dupilumab
Severe Atopic Dermatitis (Ad)
Phase IV
Not Yet Recruiting
Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab
Sep 15, 2025
―
Apixaban, Regn7508, Regn9933
Atrial Fibrillation (Af)
Phase II
Not Yet Recruiting
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
Sep 09, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Regeneron (REGN) have in its pipeline
REGN is currently developing the following drugs: Mibavademab, Mibavademab, Regn7041. These drug candidates are in various stages of clinical development as the company works toward FDA approval.